Bloomberg Businessweek
Bloomberg Markets: Gilead to Buy Kite for $11.9 Billion
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:11:00
- Mais informações
Informações:
Sinopse
(Bloomberg) -- Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Asthika Goonewardene Senior Analyst:Biotech Bloomberg Intelligence Discussing Gilead Sciences Inc. agreed to buy Kite Pharma Inc. for about $11.9 billion, making one of its biggest deals ever to expand beyond its eroding hepatitis C drug franchise.
